AdhereBio LLC raises $5M in first biotech capital round
AdhereBio LLC, a Delaware biotech company, is raising $5M under Regulation D exemption 6(b) with no investors yet committed. The Fort Lauderdale firm has not yet closed its first sale and requires a minimum investment of $100K per investor.
Note: Company incorporated in 2026 and filing its first Form D; no sales or investors yet committed.
How this compares
- Among 806 fund launches filed from FL in the same window it is larger than 33%; the FL median is $10M.
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
People on the filing
| Shawn Barrieau | Executive Officer |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Shawn Barrieau, Manager of Manager.
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.